FAP and neoplasm: In addition to upregulating IFN-γ expression and attenuating the tumor immunosuppressive microenvironment, the eNVs-FAP vaccine also depletes FAP+ CAFs and simultaneously induces ferroptosis in tumor cells via two different pathways [86].